PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is considered one of the best small-cap stocks with significant upside potential.
On October 15, Truist reduced the price target for PROCEPT BioRobotics Corporation from $64 to $50, while maintaining a Buy rating on the shares.
This rating update was part of a broader research note previewing the company’s fiscal outlook.
https://www.insidermonkey.com/blog/truist-lowers-pt-on-procept-biorobotics-corporation-prct-to-50-from-64-keeps-a-buy-rating-1630303/
